The P2-purinoceptor antagonist suramin is a competitive antagonist at vasoactive intestinal peptide receptors in the rat gastric fundus

British Journal of Pharmacology

Volumn 130, Issue 7, 2000, Pages 1632-1638

  Jenkinson, Karl M ^a   Reid, Julianne J ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b RMIT UNIVERSITY   (Australia)

Author keywords

ATP; Pituitary adenylate cyclase activating peptide; Rat gastric fundus; Suramin; Vasoactive intestinal peptide; VPAC receptors

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHYMOTRYPSIN A; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; ISOPRENALINE; NEUROTRANSMITTER; NITRIC OXIDE; NON ADRENERGIC NON CHOLINERGIC NEUROTRANSMITTER; PURINE P2 RECEPTOR; SURAMIN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST;

ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; ELECTROSTIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; STOMACH FUNDUS;

ADENOSINE TRIPHOSPHATE; ADRENERGIC BETA-AGONISTS; ANIMALS; BINDING, COMPETITIVE; DRUG INTERACTIONS; GASTRIC FUNDUS; ISOPROTERENOL; MALE; MUSCLE RELAXATION; NEUROPEPTIDES; NITRIC OXIDE; NITROPRUSSIDE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; SURAMIN; VASOACTIVE INTESTINAL PEPTIDE; VASODILATOR AGENTS;

EID: 0033855160     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703482     Document Type: Article

References (43)

1. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother., 14, 48-58.
2. BELAI, A., LEFEBVRE, R.A. & BURNSTOCK, G. (1991). Motor activity and neurotransmitter release in the gastric fundus of streptozotocin-diabetic rats. Eur. J. Pharmacol., 194, 225-234.
3. BELLAN, C., PIC, P., MARVALDI, J., FANTINI, J. & PICHON, J. (1991). Suramin inhibits vasoactive intestinal peptide (VIP) binding and VIP-induced cAMP accumulation into two human cancerous cell lines. Second Messengers Phosphoproteins, 13, 163-171.
4. BRIEJER, M.R., AKKERMANS, L.M.A., MEULEMANS, A.L., LEFEBVRE, R.A. & SCHUURKES, J.A.J. (1995). 5-HT-induced neurogenic relaxations of the guinea-pig proximal colon: investigation into the role of ATP and VIP as well as nitric oxide. Naunyn-Schmiedeberg's Arch. Pharmacol., 351, 126-135.
5. BRIZZOLARA, A.L., CROWE, R. & BURNSTOCK, G. (1993). Evidence for the involvement of both ATP and nitric oxide in non-adrenergic, non-cholinergic inhibitory neurotransmission in the rabbit portal vein. Br. J. Pharmacol., 109, 606-608.
6. BURNSTOCK, G., CAMPBELL, G., SATCHELL, D. & SMYTHE, A. (1970). Evidence that adenosine 5′-triphosphate or a related nucleotides is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br. J. Pharmacol., 40, 668-688.
7. BUTLER, S.J., KELLY, E.C.H., MCKENZIE, F.R., GUILD, S.B., WAKELAM, M.J.O. & MILLIGAN, G. (1988). Differential effects of suramin on the coupling of receptors to individual species of pertussis-toxin-sensitive guanine-nucleotide-binding proteins. Biochem. J., 251, 201-205.
8. D'AMATO, M., CURRÒ, D. & MONTUSCHI, P. (1992). Evidence for dual components in the non-adrenergic non-cholinergic relaxation in the rat gastric fundus: role of endogenous nitric oxide and vasoactive intestinal polypeptide. J. Auton. Nerv. Syst., 37, 175-186.
9. DANIEL, E.E., HAUGH, C., WOSKOWSKA, Z., CIPRIS, S., JURY, J. & FOX-THRELKELD, J.E.T. (1994). Role of nitric oxide-related inhibition in intestinal function: relation to vasoactive intestinal polypeptide. Am. J. Physiol., 266, G31-G39.
10. 2-purinoceptor response in smooth muscle cells of guinea-pig taenia caeci. Eur. J. Pharmacol., 166, 531-534.
11. 2-purinoceptor antagonist in the mouse vas deferens. Br. J. Pharmacol., 93, 243-245.
12. FAHRENKRUG, J. (1993). Transmitter role of vasoactive intestinal peptide. Pharmacol. Toxicol., 72, 354-363.
13. FEELISCH, M. (1991). The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol., 17 (Suppl. 3): S25-S33.
14. FORTEX, P.A.G., ELLERY, J.C. & LEW, V.L. (1973). Suramin: a potent ATPase inhibitor which acts on the inside surface of the sodium pump. Biochim. Biophys. Acta, 318, 262-272.
15. GLASGOW, I., MATTAR, K. & KRANTIS, A. (1998). Rat gastroduodenal motility in vivo: involvement of NO and ATP in spontaneous motor activity. Am. J. Physiol., 275, G889-G896.
16. GRIDER, J.R. (1993). Interplay of VIP and nitric oxide in regulation of the descending relaxation phase of peristalsis. Am. J. Physiol., 264, G334-G340.
17. GRIDER, J.R. & JIM, J.-G. (1993). Vasoactive intestinal peptide release and L-citrulline production from isolated ganglia of the myentcric plexus: evidence for regulation of vasocative intestinal peptide release by nitric oxide. Neuroscience, 54, 521-526.
18. GRIDER, J.R , MURTHY, K.S., JIN, J.-G. & MAKHLOUF, G.M. (1992). Stimulation of nitric oxide from cells by VIP: prejunctional enhancement of VIP release. Am. J. Physiol., 262, G774-G778.
19. HEINEMANN, A., SHABAZIAN, A., BARTHO, L. & HOLZER, P. (1999). Different receptors mediating the inhibitory action of exogenous ATP and endogenously released purines on guinea-pig intestinal peristalsis. Br. J. Pharmacol., 128, 313-320.
20. HOURANI, S.M.O. & CHOWN, J.A. (1989). The effects of some possible inhibitors of endonucleotidases on the breakdown and pharmacological effects of ATP in the guinea-pig urinary bladder. Gen. Pharmacol., 20, 413-416.
21. HOYLE, C.H.V. (1992). Transmission: purines. In The Autonomic Nervous System. Vol I: Autonomic Neuroeffector Mechanisms. ed. Burnstock, G. & Hoyle, C.H.V. pp. 367-407. Chur, Switzerland: Harwood Academic Publishers.
22. 2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli. Br. J. Pharmacol., 99, 617-621.
23. HUANG, R.-R.C., DEHAVEN, R.N., CHEUNG, A.H., DIEHL, R.E., DIXON, R.A.F. & STRADER, C.D. (1990). Identification of allosteric antagonists of receptor-guanine nucleotide-binding protein interactions. Mol. Pharmacol., 37, 304-310.
24. JENKINSON, K.M. & REID, J.J. (1995). Effect of diabetes on non-adrenergic, non-cholinergic nerve stimulation in longitudinal muscle of the rat gastric fundus. Br. J. Pharmacol., 116, 1551-1556.
25. JIN, J.-G. & GRIDER, J.R. (1993). Stoichiometry of VIP release and NO production during electrical field stimulation (EFS) of gastric smooth muscle. Gastroenterology, 104, A529.
26. LEFEBVRE, R.A. (1986). Study on the possible neurotransmitter of the non-adrenergic non-cholinergic innervation of the rat gastric fundus. Arch. Int. Pharmacodyn., 280 (Suppl.): 110-136.
27. LEFEBVRE, R.A, DE BEURME, F.A. & SAS, S. (1991). Effect of apamin on the responses to VIP, ATP and NANC neurone stimulation in the rat and cat gastric fundus. J. Auton. Pharmacol., 11, 73-83.
28. LI, C.G. & RAND, M.J. (1990). Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. Eur. J. Pharmacol., 191, 303-309.
29. MALLARD, N., MARSHALL, R., SITHERS, A. & SPRIGGS, B (1992). Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens. Eur. J. Pharmacol., 220, 1-10.
30. MATHARU, M.S. & HOLLINGSWORTH, M. (1992). Purinoceptors mediating relaxation and spasm in the rat gastric fundus. Br. J. Pharmacol., 106, 395-403.
31. MCCONALOGUE, K., FURNESS, J.B., VREMEC, M.A., HOLST, J.J., TORNøE E, K. & MARLEY, P.D. (1995). Histochemical, pharmacological, biochemical and chromatographic evidence that pituitary adenylyl cyclase activating peptide is involved in inhibitory neurotransmission in the taenia of the guinea-pig caecum. J. Auton. Nerv. Syst., 50, 311-322.
32. MIYATA, A., ARIMURA, A., DAHL, R.R. & MINAMINO, N. (1989). Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun., 164, 567-574.
33. MURTHY, K.S., GRIDER, J.R., JIN, J.-G. & MAKHLOUF, G.M. (1995). Interplay of VIP and nitric oxide in the regulation of neuromuscular activity in the gut. Arch. Int. Pharmacodyn., 329, 27-38.
34. OHNO, N., ITO, K.M., YAMAMOTO, Y. & SUZUKI, H. (1993). Suramin selectively inhibits the non-adrenergic, non-cholinergic junction potential in the guinea-pig stomach. Eur. J. Pharmacol., 249, 121-123.
35. OHNO, N., XUE, L., YAMAMOTO, Y. & SUZUKI, H. (1996). Properties of the inhibitory junction potential in smooth muscle of the guinea-pig gastric fundus. Br. J. Pharmacol., 117, 974-978.
36. PINNA, C., PUGLISI, L. & BURNSTOCK, G. (1998). ATP and vasoactive intestinal polypeptide relaxant responses in hamster isolated proximal urethra. Br. J. Pharmacol., 124, 1069-1074.
37. PLUJA, L., FERNANDEZ, E. & JIMENEZ, M. (1999). Neural modulation of the cyclic electrical and mechanical activity in the rat colonic circular muscle: putative role of ATP and NO. Br. J. Pharmacol., 126, 883-892.
38. ROBBERECHT, P., DE NEEF, P. & LEFEBVRE, R.A. (1998). Influence of selective VIP receptor agonists in the rat gastric fundus. Eur. J. Pharmacol., 359, 77-80.
39. 2 purinoceptors by suramin in rat hepatocytes. Eur. J. Pharmacol., 226, 363-365.
40. USDIN, T.B., BONNER, T.I. & MEZEY, É. (1994). Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology, 135, 2662-2680.
41. VOOGD, T.E., VANSTERKENBURG, E.L.M., WILTING, J. & JANSSEN, H.M. (1993). Recent research on the biological activity of suramin. Pharmacol. Rev., 45, 177-203.
42. XUE, L., FARRUGIA, G., SARR, M.G. & SZURSZEWSKI, J.H. (1999). Atp is a mediator of the fast inhibitory junction potential in human jejunal circular smooth muscle. Am. J. Physiol., 276, G1373-G1379.
43. XUE, L., IMAEDA, K., YAMAMOTO, Y. & SUZUKI, H. (1998). Effects of suramin on electrical and mechanical activities in antrum smooth muscle of the guinea-pig stomach. J. Autonom. Pharmacol., 18, 325-331.